×
搜尋
About
About SHINER
History
Research
News
Certificate/License
Events
Product
Drug Products
Medical Devices
Oral Supplements
Cooperate
Consulation Services
In-Licensing/Out-Licensing
Drug Products
Medical Devices
Oral Supplements
Contact
CH /
EN
About shinerpharm
Company Profile
Corporate Vision
Research and Development
Business Cooperation
Latest News
Latest News
Product Introduction
Drug Products
Medical Devices
Oral Supplements
Recruitment
104 Job Bank
Contact Us
Contact Us
News
HOME
News
Certificate / License
Events
Events
TFDA Approves Shiner's Phenbuty phase 4 clinical trial protocol.
15
2023-08
Certificate / License
Shiner Miaoli Zhunan Plant obtains Japan Foreign Manufacturer Accreditation.
14
2023-08
Certificate / License
Shiner Warehouse II obtains Japan Foreign Manufacturer Registration.
12
2023-06
Events
Epistatus 10 mg oromucosal solution receives TFDA approval of the specific medicinal products' importing as a special case.
22
2022-11
Events
Shiner's Permethrin 5% w/w Cream receives TFDA approval of the specific medicinal products' manufacturing as a special case.
15
2022-11
Certificate / License
Secured medical device business permits.
13
2022-01
Events
TFDA gives green light to clinical trial protocol for Shiner's new drug.
13
2020-11
Events
Shiner has inked a deal with a Swiss company for a spray-type medication targeting chemotherapy-induced oral mucositis.
21
2019-12
Events
Shiner announces our inclusion in the reference list of biopharmaceutical industry research and development service companies.
30
2019-06
Certificate / License
Shiner Zhunan Plant obtains the PIC/S GMP certification from TFDA.
28
2019-05
←
1
2
3
4
→